Related references
Note: Only part of the references are listed.Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application
Mei Gao et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)
Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Vignesh Narasimhan et al.
CLINICAL CANCER RESEARCH (2020)
Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine
Krijn K. Dijkstra et al.
CELL REPORTS (2020)
High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays
Nathalie Brandenberg et al.
NATURE BIOMEDICAL ENGINEERING (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening
Abhishekh Gupta et al.
COMMUNICATIONS BIOLOGY (2020)
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy
Else Driehuis et al.
CANCER DISCOVERY (2019)
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Salo N. Ooft et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
Patient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapy
Else Driehuis et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Pancreatic cancer organoids recapitulate disease and allow personalized drug screening
Else Driehuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Patient-derived tumor organoids for prediction of cancer treatment response
Peter W. Nagle et al.
SEMINARS IN CANCER BIOLOGY (2018)
Chemotherapy with cisplatin: insights into intracellular pH and metabolic landscape of cancer cells in vitro and in vivo
Marina V. Shirmanova et al.
SCIENTIFIC REPORTS (2017)
Spheroid arrays for high-throughput single-cell analysis of spatial patterns and biomarker expression in 3D
Delyan P. Ivanov et al.
SCIENTIFIC REPORTS (2017)
Phototoxicity in live fluorescence microscopy, and how to avoid it
Jaroslav Icha et al.
BIOESSAYS (2017)
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner et al.
NATURE METHODS (2016)
Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation
Yong-Min Choi et al.
PLOS ONE (2015)
Napsin A, a New Marker for Lung Adenocarcinoma, Is Complementary and More Sensitive and Specific Than Thyroid Transcription Factor 1 in the Differential Diagnosis of Primary Pulmonary Carcinoma Evaluation of 1674 Cases by Tissue Microarray
Bradley M. Turner et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
Yunfei Zhou et al.
CANCER RESEARCH (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Share Paper
